Guidance Document: Regulatory requirements for Drug Identification Numbers (DINs) - Summary

When Health Canada authorizes a drug to be marketed in Canada, a Drug Identification Number (DIN) is issued to the manufacturer and printed on the package labels. A DIN indicates that the evaluation of the drug determined that it met the relevant requirements of the Food and Drugs Act and its regulations and the drug has a favourable risk/benefit profile. Manufacturers of prescription and non-prescription drugs must obtain a DIN before they are marketed in Canada

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Ligne directrice : Exigences réglementaires associées à une identification numérique attribuée à une drogue (DIN) - Sommaire
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 0202-11-19 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["Document d'orientation", "exigences réglementaires", "DIN", "numéros d'identification du médicament", "résumé", "un médicament devant être commercialisé au Canada", "DIN imprimé sur les étiquettes de l'emballage", "médicaments sur ordonnance et en vente libre", "obtenir un DIN"], "en": ["Guidance document", "regulatory requirements", "DIN", "drug identification numbers", "summary", "a drug to be marketed in Canada", "DIN printed on the package labels", "prescription and non-prescription drugs", "obtain a DIN"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source